GSK can breathe a little easier after a Florida federal judge dismissed thousands of claims that Zantac and related heartburn products caused cancer, triggering a boost in premarket trading on Wednesday. Plaintiffs in the sprawling multidistrict litigation (MDL) at first attempted to link popular ranitidine heartburn products to 10 types of cancer, but later withdrew […]
The post Florida judge dismisses Zantac cancer claims against GSK, other pharmas – Endpoints News appeared first on The Black Chronicle.